The Urokinase-receptor (CD87) Is Expressed in Cells of the Megakaryoblastic Lineage

Summary Megakaryocytopoiesis is governed in the bone marrow microenvironment by cellular interactions that include various adhesion receptor systems and pericellular proteolysis for proper regulation of cell motility and differentiation. In order to define the role of cell surface molecules required for these processes, we searched for protease receptors on these cells. In an in vitro system utilizing different cell lines of the megakaryoblastic lineage (MEG-01, Dami), low level surface expression of the urokinase (uPA) receptor was noted. Following stimulation with phorbolester (PMA), a 3-6 fold higher expression of uPA receptor over a period of up to 5 days could be observed by fluorescent activated cell-sorting as well as by direct ligand-binding of amino-terminal fragment of uPA or vitronectin. Together with elevated expression of αIIbβ3-integrin (glycoprotein IIb/IIIa complex), double immuno-fluorescence staining of stimulated cells confirmed the increased cell surface localization of uPA receptor. Semi-quantitative RT-PCR, ligand blot analysis and measurement of cell-bound proteolytic activity revealed a differentiation-dependent upregulation of the uPA receptor expression in megakaryoblastic cell lines as in monocytic cells. Due to its glycolipid anchorage, incubation with phosphatidyl-inositol-specific phospholipase C reduced uPA receptor-mediated ligand binding by about 60%. uPA receptor mRNA was expressed in cultured megakaryocytes derived from bone marrow, whereas no uPA receptor mRNA was detectable in platelets. These results indicate a differentiation-dependent increase in the expression of uPA receptor in megakaryoblastic cells. The characteristics of surface expression and functionality of the receptor on megakaryocytic cells may influence their maturation by regulating cellular communication in the bone marrow micro-environment.

[1]  R. Stephens,et al.  The urokinase receptor , 1998 .

[2]  P. Carmeliet,et al.  Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  K. Preissner,et al.  The urokinase receptor is a major vitronectin-binding protein on endothelial cells. , 1996, Experimental cell research.

[4]  V. Gurewich,et al.  Evidence for a novel binding protein to urokinase-type plasminogen activator in platelet membranes. , 1996, Blood.

[5]  T. McCaffrey,et al.  THP‐1 macrophage membrane‐bound plasmin activity is up‐regulated by transforming growth factor‐β1 via increased expression of urokinase and the urokinase receptor , 1995 .

[6]  K. Preissner,et al.  The Versatility of Adhesion Receptor Ligands in Haemostasis: Morpho-Regulatory Functions of Vitronectin , 1995, Thrombosis and Haemostasis.

[7]  R. Leven Differential regulation of integrin‐mediated proplatelet formation and megakaryocyte spreading , 1995, Journal of cellular physiology.

[8]  K. Danø,et al.  The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface. , 1995, Biological chemistry Hoppe-Seyler.

[9]  G. Markus,et al.  The induction of the plasminogen activator system during phorbol ester (PMA)-induced differentiation in HL-60 leukemic cells , 1995 .

[10]  N. E. Hansen,et al.  The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria , 1995, British journal of haematology.

[11]  M. Kramer,et al.  Plasminogen activation by human keratinocytes: molecular pathways and cell-biological consequences. , 1995, Biological chemistry Hoppe-Seyler.

[12]  B. Jhun,et al.  Tyrosine kinases in megakaryocytopoiesis , 1995, Stem cells.

[13]  N. Brünner,et al.  The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion , 1995 .

[14]  S. Rosenberg,et al.  Identification of the urokinase receptor as an adhesion receptor for vitronectin. , 1994, The Journal of biological chemistry.

[15]  H. Johnsen,et al.  Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue. , 1994, American journal of clinical pathology.

[16]  I. Juhan-vague,et al.  Detection of Plasminogen Activator Inhibitor-1 (PAI-1) mRNA in Human Megakaryocytes by In Situ Hybridization , 1994, Thrombosis and Haemostasis.

[17]  Y. Kook,et al.  The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy. , 1994, The EMBO journal.

[18]  William Vainchenker,et al.  c-Mpl ligand is a humoral regulator of megakaryocytopoiesis , 1994, Nature.

[19]  N. Altszuler,et al.  Release of GPI‐anchored membrane proteins by a cell‐associated GPI‐specific phospholipase D. , 1994, The EMBO journal.

[20]  U. Weidle,et al.  Recombinant soluble urokinase receptor as a scavenger for urokinase‐type plasminogen activator (uPA) , 1994, FEBS letters.

[21]  U. Cavallaro,et al.  The urokinase receptor: Structure, regulation and inhibitor-mediated internalization , 1994 .

[22]  D. Lawrence,et al.  Both pro-uPA and uPA: PAI-1 complex bind to the alpha 2-macroglobulin receptor/LDL receptor-related protein. Evidence for multiple independent contacts between the ligands and receptor. , 1994, Annals of the New York Academy of Sciences.

[23]  R. Timpl,et al.  Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein. , 1993, The Journal of biological chemistry.

[24]  D. Waltz,et al.  Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors. , 1993, The Journal of clinical investigation.

[25]  J. Hoxie,et al.  Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways. , 1993, Circulation research.

[26]  H. Avraham Regulation of megakaryocytopoiesis , 1993, Stem cells.

[27]  F. Tablin,et al.  Extracellular matrix stimulation of guinea pig megakaryocyte proplatelet formation in vitro is mediated through the vitronectin receptor. , 1992, Experimental hematology.

[28]  L. Lund,et al.  Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. , 1992, The Journal of biological chemistry.

[29]  I. Mizukami,et al.  cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. , 1992, Journal of immunology.

[30]  N. E. Hansen,et al.  The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria. , 1992, Blood.

[31]  F. Blasi,et al.  In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion , 1991, The Journal of cell biology.

[32]  R. Ware,et al.  Paroxysmal nocturnal hemoglobinuria with onset in childhood and adolescence. , 1991, The New England journal of medicine.

[33]  J. Gabrilove,et al.  Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan , 1991, The Journal of cell biology.

[34]  L. Lund,et al.  Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells. , 1991, The Journal of biological chemistry.

[35]  B. Coller,et al.  Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIA and alpha v beta 3 integrins in platelet protein trafficking. , 1991, Blood.

[36]  L. Lund,et al.  The urokinase receptor and regulation of cell surface plasminogen activation. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.

[37]  R. Leven,et al.  Collagenase production by guinea pig megakaryocytes in vitro. , 1990, Experimental hematology.

[38]  K. Preissner,et al.  Specific binding of plasminogen to vitronectin. Evidence for a modulatory role of vitronectin on fibrin(ogen)-induced plasmin formation by tissue plasminogen activator. , 1990, Biochemical and biophysical research communications.

[39]  E. Appella,et al.  The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. , 1990, The Journal of biological chemistry.

[40]  E. Appella,et al.  Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. , 1990, The EMBO journal.

[41]  M. Lieberman,et al.  In vitro establishment and characterization of a human megakaryoblastic cell line. , 1990, Blood.

[42]  J. Freyssinet,et al.  Stability of the thrombin-thrombomodulin complex on the surface of endothelial cells from human saphenous vein or from the cell line EA.hy 926. , 1989, The Biochemical journal.

[43]  Y. Sultan,et al.  Tissue Plasminogen Activator in Human Megakaryocytes and Platelets: Immunocytochemical Localization, Immunoblotting and Zymographic Analysis , 1988, Thrombosis and Haemostasis.

[44]  K. Preissner,et al.  Attachment of cultured human endothelial cells is promoted by specific association with S protein (vitronectin) as well as with the ternary S protein-thrombin-antithrombin III complex. , 1988, Blood.

[45]  F. Blasi,et al.  A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification. , 1988, The Journal of biological chemistry.

[46]  B. Haendler,et al.  Complementary DNA for human T‐cell cyclophilin. , 1987, The EMBO journal.

[47]  A. Corti,et al.  Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[48]  D. Belin,et al.  A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase , 1985, The Journal of cell biology.

[49]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.

[50]  C. Edgell,et al.  Permanent cell line expressing human factor VIII-related antigen established by hybridization. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[51]  D. Deutsch,et al.  Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.